OUR STORY

Gemstone Biotherapeutics was founded in Baltimore, MD in 2013, with an IP portolio exclusively licensed IP from The Johns Hopkins University. We are focused on commercializing our Extracellular Matrix Replacement (EMR) technology that yields robust skin regeneration in preclinical studies. Our management team has the expertise and passion to drive commercialization and build a strong pipeline of dermatology products.

 

We collaborate with world class researchers at the Johns Hopkins University and the University of Pennsylvania. Our pipeline of assets with rapid commercialization potential has the potential to yield multiple high-value products.

Our Team

Emily English

Emily English, Ph.D.

Chief Executive Officer

Dr. English is a seasoned leader with 10+ years’ technical and entrepreneurial management experience. Since being recruited to Gemstone Bio, she has aligned the company’s strategy to focus on a lead product in the dermatology space that can deliver significant clinical impact and value creation. She has built a multi-disciplinary team with experts in commercialization strategy, regulatory affairs, and clinical and preclinical research. Prior to joining Gemstone Bio, Dr. English was a Program Manager at the Johns Hopkins University Applied Physics Laboratory, where she oversaw a portfolio of developmental and operational programs serving US government sponsors. She holds PhD and BS degrees in chemistry from the University of Wisconsin – Madison and the University of Maryland – College Park.

Matt Davenport

Matt Davenport

Director of Engineering

Matt graduated from The Johns Hopkins University with a BS/MSE in Chemical and Biomolecular Engineering. At Johns Hopkins, Matt worked in the lab of Dr. Sharon Gerecht and was a key researcher in the development of Gemstone’s core technology. He brings a vast background in material science, bioengineering, and downstream processing to Gemstone. His past research experiences include Myriant Technologies and the European Molecular Biology Laboratories (EMBL).

Janty Shoga

Janty Shoga

Research Engineer

Janty graduated from the Univ. of Delaware with a BS in Mechanical Engineering and an MS in Biomechanics. At the Univ. of Delaware, Janty’s research focused on the solid and fluid mechanics involved in musculoskeletal tissues and how these macroscale mechanics affect microscale cell behavior. Prior to joining Gemstone, Janty was the Lead Product Development Engineer at JADE Biotech, a startup that aimed to create a device to manage and audit medical narcotic waste.

Inventors

Sharon Gerecht, Ph.D.

Johns Hopkins University

Professor of Chemical & Biomolecular Engineering and Materials Science at the Whiting School of Engineering.  Director of the Institute for NanoBio Technology (INBT).

Jeremy Walston, MD

Johns Hopkins Bayview Medical Center

Raymond and Anna Lublin Professor of Geriatric Medicine at JHMI; Co-Director of the Biology of Healthy Aging Program in the Division of Geriatric Medicine and Gerontology.

Peter Abadir, MD

Johns Hopkins Bayview Medical Center

Assistant Professor of Geriatric Medicine and Gerontology at JHMI.

Scientific Advisory Board

Susan Volk, Ph.D., V.M.D.

University of Pennsylvania

Associate Professor of Small Animal Surgery, School of Veterinary Medicine, University of Pennsylvania.

Ronald Sherman, D.P.M., MBA

The Johns Hopkins Hospital

Podiatric Surgeon in the Dept of Surgery: Division of Vascular Surgery at Johns Hopkins Hospital.  Member of the Multidisciplinary Diabetic Foot & Wound Clinic.

Marc Dauer, MD

Dauer Hair Restoration

Medical Director of Dauer Hair Restoration.

David Abramson, MD

Englewood Hospital, Mt. Sinai School of Medicine

Chief of Plastic Surgery at Englewood Hospital.  Associate Clinical Professor of Surgery at Mt. Sinai School of Medicine.

Board of Directors

David Oros

Gamma 3

Founding Partner of Gamma 3 LLC.  Chairman of Gemstone and Terbium Labs.  Former Chairman and CEO of Aether Systems, Inc.

 

Geoff Mackay

AVROBIO

Founder, President and CEO of AVROBIO, Inc. in Cambridge, MA. Former Chairman of the Board of the Alliance for Regenerative Medicine, and former President and CEO of Organogenesis.

Xin Huang, MD, Ph.D.

Cowin Venture Capital

Managing Partner at Cowin Venture and leader of the firm’s healthcare sector.

Our Collaborators

Polysciences Inc
Idfive
Abel Communications
Fast Forward
Katecho
Polymer Solutions
Biologics

Join Our Team

Interested in our work? Then we’re interested in you.